Allergic Bronchopulmonary AspergillosisSymptoms, Doctors, Treatments, Advances & More
Learn About Allergic Bronchopulmonary Aspergillosis
- Allergic bronchopulmonary aspergillosis
- ABPA
- Allergic bronchopulmonary mycosis
- Aspergillosis, allergic bronchopulmonary
- Hinson-Pepys disease
Emory Clinic - Pulmonology At Executive Park
Frances Lee is an Allergy and Immunologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 33 years. Dr. Lee is rated as an Elite provider by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Asthma, and Pulmonary Aspergilloma. Dr. Lee is board certified in American Board Of Internal Medicine, 2000.
Tsuyoshi Oguma practices practicing medicine in Kyoto, Japan. Mr. Oguma is rated as an Elite expert by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Asthma, Lung Transplant, and Endoscopy.
DM Wayanad Institute Of Medical Sciences
Ritesh Agarwal practices practicing medicine in Wayanad, India. Mr. Agarwal is rated as an Elite expert by MediFind in the treatment of Allergic Bronchopulmonary Aspergillosis. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Sarcoidosis, Endoscopy, and Lung Transplant.
Summary: An open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis
Summary: While ABPA and CPA represent two distinct manifestations of Aspergillus-related lung disease, there is an overlap of investigations that are currently used for the diagnosis of these entities. In a previous study, the authors have demonstrated that 22% of subjects with CPA fulfilled the obligatory criteria for ABPA. While the preferable therapy in patients with ABPA is systemic glucocorticoids, th...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center